Logos Global Management LP Inhibrx, Inc. Transaction History

Logos Global Management LP

  • $1.07 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$14.5 - $38.0 $1.45 Million - $3.8 Million
100,000 New
100,000 $3.8 Million
Q4 2020

Feb 16, 2021
SELL
$15.96 - $50.0 $4.97 Million - $15.6 Million
-311,578 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$16.77 - $20.65 $5.23 Million - $6.43 Million
311,578 New
311,578 $5.61 Million

Others Institutions Holding INBX

# of Institutions
2
Shares Held
25.3K
Call Options Held
0
Put Options Held
0
View Full List

About Inhibrx, Inc.

INBX Quotes by TradingView
  • Ticker INBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,057,700
  • Market Cap $617M
  • Description
  • Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...
More about INBX
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email